GSK : Summary for GlaxoSmithKline PLC Common Stoc - Yahoo Finance

U.S. Markets closed

GlaxoSmithKline plc (GSK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
37.70+0.27 (+0.72%)
At close: 4:02 PM EST

37.66 -0.04 (-0.10%)
After hours: 5:45 PM EST

People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close37.43
Bid37.71 x 100
Ask38.24 x 1000
Day's Range37.46 - 37.85
52 Week Range37.36 - 45.58
Avg. Volume3,548,717
Market Cap93.89B
PE Ratio (TTM)244.81
Earnings DateN/A
Dividend & Yield1.86 (4.91%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • TheStreet.com3 hours ago

    How to Buy GlaxoSmithKline at a 15% Discount

    Investors seeking more returns can not only get some yield, but also healthy dividends from buying options on stocks. Those who are seeking additional opportunities can purchase GlaxoSmithKline (GSK),

  • GlaxoSmithKline PLC (ADR) (GSK) Wins Approval Of Its Asthma Drug Nucala
    Insider Monkey5 hours ago

    GlaxoSmithKline PLC (ADR) (GSK) Wins Approval Of Its Asthma Drug Nucala

    The National Institute for Health and Care Excellence (NICE) has confirmed the approval of a new injectable asthma drug from GlaxoSmithKline PLC (ADR) (NYSE:GSK). Nucala, a first-in-class antibody treatment had earlier suffered a major setback of rejection, which had been occasioned by cost-effectiveness concerns. NICE had also claimed that the drug would be used in less […]

  • Investopedia7 hours ago

    Glaxo and Innoviva Get Positive News (GSK, INVA)

    Glaxo and Innoviva are moving higher on the heels of positive news in both Europe and Japan for a COPD drug.